May 20, 2025 - 23:05

Microsoft has acknowledged that it provided artificial intelligence technology to the Israel Ministry of Defense (IMOD). However, the company emphasized that there is "no evidence" to suggest that this technology has been utilized to target or harm individuals amid the ongoing conflict in Gaza. This statement comes in response to growing scrutiny over the ethical implications of technology companies supplying defense capabilities to military organizations.
The tech giant's clarification aims to address concerns raised by various human rights groups and activists who fear that advanced AI tools could be misused in military operations. Microsoft asserts its commitment to responsible AI use and stresses that its technology is designed to enhance safety and security rather than contribute to violence.
As the conflict continues, the intersection of technology and warfare remains a critical topic of discussion, with calls for greater accountability and transparency from tech firms involved in defense contracts.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...